Marrone Bio Innovations MBII announces its next round of earnings this Monday, August 10. Here is Benzinga's everything-that-matters guide for this Monday's Q2 earnings announcement.
Earnings and Revenue
Wall Street analysts see Marrone Bio Innovations reporting a quarterly EPS of $-0.04 per share on sales of $10.38 million. In the same quarter last year, Marrone Bio Innovations posted EPS of $-0.06 on sales of $7.00 million. If the company were to match the consensus estimate when it reports Monday, earnings would be up 33.33%. Revenue would be up 2.67% from the same quarter last year. Here's how the company's EPS has stacked up against analyst estimates in the past:
|Quarter||Q1 2020||Q4 2020||Q3 2019||Q2 2019|
|Revenue Estimate||10.11 M||7.34 M||6.95 M||8.33 M|
|Revenue Actual||9.65 M||6.70 M||6.97 M||7.00 M|
Over the past 52-week period, shares of Marrone Bio Innovations have declined 4.63%. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. Marrone Bio Innovations is scheduled to hold the call at 16:30:00 ET and can be accessed here: https://viavid.webcasts.com/starthere.jsp?ei=1348996&tp_key=2053189d5f
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.